August 13, 2018 Autophagy is a process of destruction and processing of damaged cell components by the cells themselves. It is used by a cell to clean itself of excessive organelles and sometimes for self-execution. This adaptive mechanism supports a healthy phenotype on the cellular level. Autophagy is activated in certain cases of acute kidney […]Continue Reading ...
August 13, 2018 Scientists have discovered a new blood biomarker that could help predict the risk of kidney cancer. The research was recently published in the journal Clinical Cancer Research. Supported by Cancer Research UK, the IARC and the NIH, the work used samples taken as part of the EPIC study to examine the blood […]Continue Reading ...
August 13, 2018 Scientists have discovered that a marker in the blood could help predict the risk that a person will develop kidney cancer, according to research published in the journal Clinical Cancer Research. Supported by Cancer Research UK, the IARC and the NIH, the work used samples taken as part of the EPIC study […]Continue Reading ...
August 10, 2018 A critical biomarker of kidney disease may help predict clear cell kidney cancer – the most common form of kidney cancer – years before clinical diagnosis. Kidney-injury-molecule-1 (KIM-1) can be detected in the urine and blood and is generally present at low levels in healthy individuals. Prior research by leaders at Brigham […]Continue Reading ...
TUESDAY, July 31, 2018 — Losing a leg is one of the most traumatic consequences of advanced kidney disease, but the risk of amputations has dropped significantly since 2000, a new study finds. Between 2000 and 2014, amputations among U.S. patients with end-stage kidney disease who were receiving dialysis were cut by 51 percent. Despite […]Continue Reading ...
People with chronic kidney disease are at unusually high risk of also developing cardiovascular disease; in fact, a patient with non-dialysis kidney disease is more likely to die of heart failure than to develop end-stage kidney failure.Continue Reading ...
July 19, 2018 New research provides support for the long-term efficacy of a drug used to treat in patients with autosomal dominant polycystic kidney disease (ADPKD), a common cause of kidney failure. The findings appear in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN). The hormone vasopressin promotes the […]Continue Reading ...
July 16, 2018 Trauma is the sixth leading cause of death worldwide, and recent studies suggest that 16 percent of renal (kidney) trauma occurs from a penetrating injury, such as a gunshot wound, stabbing or piercing injury from a car accident. If a patient is bleeding to death from the kidney, surgery can be life-saving. […]Continue Reading ...
August 13, 2018 According to a new review, approximately 30 million Americans – about 15 percent of adults – have chronic kidney disease, a number that is expected to increase in the next 20 years due to rising obesity rates and longer lifespans, but the majority of chronic kidney disease patients aren’t receiving potentially lifesaving […]Continue Reading ...
August 10, 2018 New research from the UBC Sauder School of the Business has found that transplant societies which prioritize kidney transplant chains over kidney exchanges can increase the total number of transplants, thereby saving more lives. Typically, kidney donations are allocated in a kidney exchange, where pools of patients are each paired with a […]Continue Reading ...
August 9, 2018 Older kidney disease patients who are sick enough to require the blood-filtering treatment known as dialysis are at high risk of dementia, including Alzheimer’s disease, according to a study led by scientists at Johns Hopkins Bloomberg School of Public Health. The study, published Aug. 9 in the Clinical Journal of the American […]Continue Reading ...
August 2, 2018 Otsuka Pharmaceutical Europe Ltd. (OPEL) today announced that the European Commission has approved an extension of indication for JINARC® (tolvaptan) to include adult patients with CKD stage 4 Autosomal Dominant Polycystic Kidney Disease (ADPKD). JINARC® was approved in 2015 for the treatment of ADPKD in adults with CKD stage 1-3 at initiation […]Continue Reading ...
July 24, 2018 The lifespan of a transplant kidney has significantly improved over the last thirty years. Between 1986 and 1995, 75% of the transplanted kidneys still functioned five years after the transplant. Between 2006 and 2015, this number had already risen to 84%. However, an international study lead by kidney specialist Maarten Naesens of […]Continue Reading ...
July 20, 2018 University of North Carolina Lineberger Comprehensive Cancer Center scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. Scientists have known this genetic change can lead to an overabundance of blood vessels, which help feed nutrients to the tumors. Their latest finding shows a potential new […]Continue Reading ...
July 16, 2018 A new, painless, non-invasive procedure that harnesses ultrasound technology to reposition kidney stones, in an effort to offer the sufferer quick relief, will undergo testing in emergency patients. The development and assessment of the new technology is led by University of Washington and UW Medicine, in collaboration with other universities and agencies. […]Continue Reading ...
- Researchers win multi-million Euro award to conduct research into liver disease
- Survey highlights variations in practice of airway management in pediatric intensive care units
- UK students win sponsorship from Promega Corporation
- Janssen Reports Positive Topline Results for ATLAS Phase III Study of a Novel, Long Acting Injectable Two-Drug Regimen for the treatment of HIV-1
- PSD as a molecular platform for understanding synapse formation and plasticity
- Improved visual communication could help patients to make informed health-care decisions
- New algorithm helps identify and manage diabetic patients at increased fracture risk
- Microscopic insect odour detecting mechanisms discovered
- Researchers develop new approach to study how tuberculosis infects people
- FDA Approves Kalydeco (ivacaftor) for Cystic Fibrosis in Children Ages 12 to
- An ion channel differentiates newborn and mature neurons in the adult brain
- Socio-economic position associated with pregnant women’s exposure to environmental hazards
- Voters to settle dispute over ambulance employee break times
- AGA urges policymakers and stakeholders to improve affordability of drugs
- Increasing dietary protein may lower risk of diabetes in people with NAFLD
- New HIV therapy suppresses viral replication and increases immune cells in drug-resistant patients
- Broad Genetic Testing for NSCLC May Not Improve Survival
- Discovery opens door for synthetic opioids with less addictive qualities
- Transgenic rice plant extracts could help stop the spread of HIV
- Hologic’s Cynosure division partners with Porter Instrument to distribute nitrous oxide and oxygen system